120103-18-6 Usage
General Description
2,5-DIFLUORO-4-NITROPHENOL is a chemical compound with the molecular formula C6H3F2NO3. It is a pale yellow to brown crystalline solid that is used primarily as an intermediate in the synthesis of pharmaceuticals and agrochemicals. This chemical is known for its strong acidic nature and is commonly used as a building block for various industrial products. It is considered to be moderately toxic and can cause irritation to the skin, eyes, and respiratory system upon exposure. 2,5-DIFLUORO-4-NITROPHENOL is also known to have potential environmental impacts and should be handled and disposed of with care to prevent harm to humans and the environment.
Check Digit Verification of cas no
The CAS Registry Mumber 120103-18-6 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 1,2,0,1,0 and 3 respectively; the second part has 2 digits, 1 and 8 respectively.
Calculate Digit Verification of CAS Registry Number 120103-18:
(8*1)+(7*2)+(6*0)+(5*1)+(4*0)+(3*3)+(2*1)+(1*8)=46
46 % 10 = 6
So 120103-18-6 is a valid CAS Registry Number.
InChI:InChI=1/C6H3F2NO3/c7-3-2-6(10)4(8)1-5(3)9(11)12/h1-2,10H
120103-18-6Relevant articles and documents
ALKYNE COMPOUNDS AS S-NITROSOGLUTATHIONE REDUCTASE INHIBITORS
-
Page/Page column 75; 81, (2016/05/02)
Provided are compounds of formula (Ia) and pharmaceutically acceptable salts thereof, wherein A, B, R 1, R 2, m and n are as defined herein, which are active as inhibitors of S-Nitrosoglutathione reductase (GSNOR). These compounds prevent, inhibit, or suppress the action of GSNOR and are therefore useful in the treatment of GSNOR mediated diseases, disorders, syndromes or conditions such as, e.g., pulmonary hypertension, acute respiratory distress syndrome (ARDS), asthma, bronchospasm, cough, pneumonia, pulmonary fibrosis, interstitial lung diseases, cystic fibrosis and chronic obstructive pulmonary disease (COPD).
Substituted pyridinyl and pyrimidinyl derivatives as modulators of metabolism and the treatment of disorders related thereto
-
Page/Page column 48, (2008/06/13)
The present invention relates to certain substituted pyridinyl and pyrimidinyl derivatives of Fomula (Ia) that are modulators of metabolism. Accordingly, compounds of the present invention are useful in the treatment of metabolic-related disorders and com
